Contact
Please use this form to send email to PR contact of this press release:
FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients
TO:
Please use this form to send email to PR contact of this press release:
FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients
TO: